Joao Gomes-Canto
Braga, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to "Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis" [Int. Immunopharmacol. 131 (2024) 111826].
Journal: International immunopharmacology
Published: November 05, 2024
Lipid Priming of Adipose Mesenchymal Stromal Cells with Docosahexaenoic Acid: Impact on Cell Differentiation, Senescence and the Secretome Neuroregulatory Profile.
Journal: Tissue engineering and regenerative medicine
Published: August 23, 2024
Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis.
Journal: International immunopharmacology
Published: December 01, 2023
HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation.
Journal: Science immunology
Published: June 30, 2023
Low Memory T Cells Blood Counts and High Naïve Regulatory T Cells Percentage at Relapsing Remitting Multiple Sclerosis Diagnosis.
Journal: Frontiers in immunology
Published: March 21, 2022
High Dimensional Immune Profiling Reveals Different Response Patterns in Active and Latent Tuberculosis Following Stimulation With Mycobacterial Glycolipids.
Journal: Frontiers in immunology
Published: June 18, 2021
Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalised COVID-19 patients.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: October 14, 2020
Thymic Function as a Predictor of Immune Recovery in Chronically HIV-Infected Patients Initiating Antiretroviral Therapy.
Journal: Frontiers in immunology
Published: October 08, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026